Lifastuzumab vedotin (ADC)
Lifastuzumab vedotin is an ADC consisting of a NaPi2b-directed antibody and Monomethyl auristatin E (MMAE) used for the study of non-small cell lung cancer.
Product Specifications
Product Name Alternative
RG7599, DNIB0600A
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC741802-100 1x 100 µL
CD40 / TNFRSF5 / CD40L-Receptor (T8P2G4*A6), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 